New Aseptic Micro-Connector for CGT Applications
CPC (Colder Products Company), part of Dover Corporation and a leader in connection technologies for biopharmaceutical processing, has recently launched an innovative aseptic micro-connector. This connector is specifically made for integration into freeze cassettes used in cell and gene therapy (CGT) processing. This groundbreaking product aims to set new standards for cryopreservation, a critical process that freezes biological materials in CGT, protecting their functionality during transit and storage.
Why Cryopreservation Matters
Cryopreservation is essential to the success of cell and gene therapies. As these therapies are transported to patients, there's a substantial risk that biological materials could degrade. By allowing storage at extremely low temperatures, this method preserves the integrity of these materials all the way to their final destination.
Introducing the MicroCNX ULT Series
The MicroCNX ULT Series is tailored to meet the strict demands of contemporary cell therapy processes, able to endure temperatures as low as -190°C. Troy Ostreng, Senior Product Manager for CPC's biopharmaceutical division, notes that not only does the micro-connector ensure sterility, but its compact design allows it to fit effortlessly into CGT freeze cassettes, providing both practicality and efficiency throughout the therapy development journey.
Key Features of the MicroCNX ULT Connectors
The MicroCNX ULT connectors are changing the game for sterile connections within small-format systems used in cell and gene therapy. Their design guarantees compatibility with the aggressive solvents often used in cryopreservation, such as dimethyl sulfoxide (DMSO), as well as with various common tubing types like polyvinyl chloride (PVC).
Building on a Legacy of Innovation
The launch of the MicroCNX ULT Series is a continuation of CPC’s trailblazing efforts, including the MicroCNX Series, recognized as the smallest connector available for making closed sterile connections with minimal volumes. This alternative to tube welding has established a new benchmark in the industry.
Recent Product Innovations
In a related development, CPC also recently introduced MicroCNX Luers, which provide enhanced connectivity options for manufacturers that need to establish sterile connections outside biosafety cabinets. This adaptability has been well-received in the industry, offering comprehensive solutions that fit specific operational needs.
CPC's Future Vision
As a frontrunner in aseptic connection technology, CPC is dedicated to assisting its customers from initial development through commercialization. Ostreng emphasizes that their wide-ranging portfolio of aseptic connectors enables CPC to respond effectively to the evolving landscape of cell therapy, gene therapy, and biopharmaceutical manufacturing around the world.
For more information on the MicroCNX series connectors and the cutting-edge solutions provided by CPC, visit their website to discover the full range of products and services designed to improve biopharmaceutical processing operations.
About CPC
CPC (Colder Products Company) specializes in single-use connection technology, offering a diverse range of connectors for biopharmaceutical manufacturing processes. Their products strive to maintain sterility and media integrity while ensuring efficient production yields. Notably, the AseptiQuik® connectors allow for fast sterile connections, even in challenging conditions.
About Dover Corporation
Dover Corporation is a well-established global manufacturer that delivers innovative solutions across various sectors, achieving annual revenue exceeding $8 billion. With around 25,000 employees dedicated to redefining industry standards, Dover’s operational agility positions them to meet diverse customer needs effectively. The company's stock is traded on the New York Stock Exchange under the ticker symbol DOV.
Frequently Asked Questions
What is the purpose of the MicroCNX ULT Series?
The MicroCNX ULT Series is built to facilitate sterile connections in cell and gene therapy processes, ensuring they can handle extreme temperatures and harsh chemicals.
How does cryopreservation impact cell therapy?
Cryopreservation helps minimize the risk of functional loss in biological materials critical for cell therapy during transport and storage.
Who owns CPC?
CPC is a division of Dover Corporation, a leader in global manufacturing.
What innovations does the MicroCNX series provide?
The MicroCNX series features a compact design that can endure low temperatures and is compatible with solvents used in cryopreservation.
How does CPC assist its customers?
CPC offers comprehensive support from the development phase through to commercialization, simplifying the process of establishing sterile connections for its customers.
